AHR- and DNA-damage-mediated gene expression responses induced by benzo(a)pyrene in human cell lines

Chemical Research in Toxicology

Volumn 20, Issue 12, 2007, Pages 1797-1810

  Hockley, Sarah L ^a   Arlt, Volker M ^a   Brewer, Daniel ^a   Te Poele, Robert ^b   Workman, Paul ^b   Giddings, Ian ^a   Phillips, David H ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; COMPLEMENTARY DNA; CYTOCHROME P450 1B1; DNA;

APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL LINE; CELL STRAIN HEPG2; CELL STRAIN MCF 7; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; DNA MICROARRAY; DNA REPAIR; GENE CONTROL; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; UPREGULATION; XENOBIOTIC METABOLISM;

BENZO(A)PYRENE; BINDING SITES; CARCINOGENS, ENVIRONMENTAL; CELL LINE, TUMOR; CELL SURVIVAL; CYTOCHROME P-450 CYP1A1; DNA ADDUCTS; DNA DAMAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRACHLORODIBENZODIOXIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 38149063931     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx700252n     Document Type: Article

References (55)

1. Bostrom, C. E., Gerde, P., Hanberg, A., Jernstrom, B., Johansson, C., Kyrklund, T., Rannug, A., Tornqvist, M., Victorin, K., and Westerholm, R. (2002) Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ. Health Perspect. 110 (Suppl. 3), 451-488.
2. Phillips, D. H. (1999) Polycyclic aromatic hydrocarbons in the diet. Mutat. Res. 443 (1-2), 139-147.
3. Sims, P., Grover, P. L., Swaisland, A., Pal, K., and Hewer, A. (1974) Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide. Nature 252 (5481), 326-328.
4. Denissenko, M. F., Pao, A., Tang, M., and Pfeifer, G. P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 274 (5286), 430-432.
5. Staal, Y. C., van Herwijnen, M. H., van Schooten, F. J., and van Delft, J. H. (2006) Modulation of gene expression and DNA adduct formation in HepG2 cells by polycyclic aromatic hydrocarbons with different carcinogenic potencies. Carcinogenesis 27 (3), 646-655.
6. Mahadevan, B., Keshava, C., Musafia-Jeknic, T., Pecaj, A., Weston, A., and Baird, W. M. (2005) Altered gene expression patterns in MCF-7 cells induced by the urban dust particulate complex mixture standard reference material 1649a. Cancer Res. 65 (4), 1251-1258.
7. van Delft, J. H., van Agen, E., van Breda, S. G., Herwijnen, M. H., Staal, Y. C., and Kleinjans, J. C. (2004) Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling. Carcinogenesis 25 (7), 1265-1276.
8. Bartosiewicz, M., Penn, S., and Buckpitt, A. (2001) Applications of gene arrays in environmental toxicology: Fingerprints of gene regulation associated with cadmium chloride, benzo(a)pyrene, and trichloroethylene. Environ. Health Perspect. 109 (1), 71-74.
9. Yu, Z., Ford, B. N., and Glickman, B. W. (2000) Identification of genes responsive to BPDE treatment in HeLa cells using cDNA expression assays. Environ. Mol. Mutagen. 36 (3), 201-205.
10. Akerman, G. S., Rosenzweig, B. A., Domon, O. E., McGarrity, L. J., Blankenship, L. R., Tsai, C. A., Culp, S. J., MacGregor, J. T., Sistare, F. D., Chen, J. J., and Morris, S. M. (2004) Gene expression profiles and genetic damage in benzo(a)pyrene diol epoxide-exposed TK6 cells. Mutat. Res. 549 (1-2), 43-64.
11. Luo, W., Fan, W., Xie, H., Jing, L., Ricicki, E., Vouros, P., Zhao, L. P., and Zarbl, H. (2005) Phenotypic anchoring of global gene expression profiles induced by N-hydroxy-4-acetylaminobiphenyl and benzo[a]pyrene diol epoxide reveals correlations between expression profiles and mechanism of toxicity. Chem. Res. Toxicol. 18 (4), 619-629.
12. Hockley, S. L., Arlt, V. M., Brewer, D., Giddings, I., and Phillips, D. H. (2006) Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2. BMC Genomics 7, 260.
13. Machala, M., Vondracek, J., Blaha, L., Ciganek, M., and Neca, J. V. (2001) Aryl hydrocarbon receptor-mediated activity of mutagenic polycyclic aromatic hydrocarbons determined using in vitro reporter gene assay. Mutat. Res. 497 (1-2), 49-62.
14. Tsuchiya, Y., Nakajima, M., Itoh, S., Iwanari, M., and Yokoi, T. (2003) Expression of aryl hydrocarbon receptor repressor in normal human tissues and inducibility by polycyclic aromatic hydrocarbons in human tumor-derived cell lines. Toxicol. Sci. 72 (2), 253-259.
15. Nebert, D. W., Puga, A., and Vasiliou, V. (1993) Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann. N. Y. Acad. Sci. 685, 624-640.
16. Shimada, T., Sugie, A., Yamada, T., Kawazoe, H., Hashimoto, M., Azuma, E., Nakajima, T., Inoue, K., and Oda, Y. (2003) Dose-response studies on the induction of liver cytochromes P450 1A1 and 1B1 by polycyclic aromatic hydrocarbons in arylhydrocarbon-responsive C57BL/6J mice. Xenobiotica 33 (9), 957-971.
17. Nebert, D. W., Dalton, T. P., Okey, A. B., and Gonzalez, F. J. (2004) Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 279 (23), 23847-23850.
18. Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., Fujii-Kuriyama, Y., and Ishikawa, T. (2000) Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U.S.A. 97 (2), 779-782.
19. Lakin, N. D., and Jackson, S. P. (1999) Regulation of p53 in response to DNA damage. Oncogene 18 (53), 7644-7655.
20. Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88 (3), 323-331.
21. Porta, C., Hadj-Slimane, R., Nejmeddine, M., Pampin, M., Tovey, M. G., Espert, L., Alvarez, S., and Chelbi-Alix, M. K. (2005) Interferons α and γ induce p53-dependent and p53-independent apoptosis, respectively. Oncogene 24 (4), 605-615.
22. Lee, T. K., Lau, T. C., and Ng, I. O. (2002) Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines. Cancer Chemother. Pharmacol. 49 (1), 78-86.
23. Harvey, R. G., and Fu, P. P. Synthesis and reactions of diol epoxides and related metabolites of carcinogenic hydrocarbons, in Polycyclic Hydrocarbons and Cancer, pp 133-165, Gelboin, H. V., and Ts'O, P. O. P. e., Eds., Academic Press, New York, 1978.
24. Bajic, V. B., Seah, S. H., Chong, A., Zhang, G., Koh, J. L., and Brusic, V. (2002) Dragon Promoter Finder: recognition of vertebrate RNA polymerase II promoters. Bioinformatics 18 (1), 198-199.
25. Kel, A., Kel-Margoulis, O., Babenko, V., and Wingender, E. (1999) Recognition of NFATp/AP-1 composite elements within genes induced upon the activation of immune cells. J. Mol. Biol. 288 (3), 353-376.
26. Nebert, D. W., Roe, A. L., Dieter, M. Z., Solis, W. A., Yang, Y., and Dalton, T. P. (2000) Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol. 59 (1), 65-85.
27. Schmidt, J. V., and Bradfield, C. A. (1996) Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12, 55-89.
28. Gonzalez, F. J., and Fernandez-Salguero, P. (1998) The aryl hydrocarbon receptor: Studies using the AHR-null mice. Drug Metab. Dispos. 26 (12), 1194-1198.
29. Nioi, P., and Hayes, J. D. (2004) Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat. Res. 555 (1-2), 149-171.
30. Nebert, D. W., and Vasiliou, V. (2004) Analysis of the glutathione S-transferase (GST) gene family. Hum. Genomics 1 (6), 460-464.
31. Kim, J. H., Stansbury, K. H., Walker, N. J., Trush, M. A., Strickland, P. T., and Sutter, T. R. (1998) Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis. 19 (10), 1847-1853.
32. Williams, J. A., Martin, F. L., Muir, G. H., Hewer, A., Grover, P. L., and Phillips, D. H. (2000) Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue. Carcinogenesis 21 (9), 1683-1689.
33. Karyala, S., Guo, J., Sartor, M., Medvedovic, M., Kann, S., Puga, A., Ryan, P., and Tomlinson, C. R. (2004) Different global gene expression profiles in benzo[a]pyrene- and dioxin-treated vascular smooth muscle cells of AHR-knockout and wild-type mice. Cardiovasc. Toxicol. 4 (1), 47-73.
34. Puga, A., Barnes, S. J., Dalton, T. P., Chang, C., Knudsen, E. S., and Maier, M. A. (2000) Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J. Biol. Chem. 275 (4), 2943-2950.
35. Ge, N. L., and Elferink, C. J. (1998) A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. Linking dioxin signaling to the cell cycle. J. Biol. Chem. 273 (35), 22708-22713.
36. Kim, D. W., Gazourian, L., Quadri, S. A., Romieu-Mourez, R., Sherr, D. H., and Sonenshein, G. E. (2000) The RelA NF-κ subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene 19 (48), 5498-5506.
37. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., and Vogelstein, B. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282 (5393), 1497-1501.
38. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75 (4), 805-816.
39. Ohtsuka, T., Jensen, M. R., Kim, H. G., Kim, K. T., and Lee, S. W. (2004) The negative role of cyclin G in ATM-dependent p53 activation. Oncogene 23 (31), 5405-5408.
40. Kawakubo, H., Carey, J. L., Brachtel, E., Gupta, V., Green, J. E., Waiden, P. D., and Maheswaran, S. (2004) Expression of the NF-κB- responsive gene BTG2 is aberrantly regulated in breast cancer. Oncogene 23 (50), 8310-8319.
41. Jeffy, B. D., Chen, E. J., Gudas, J. M., and Romagnolo, D. F. (2000) Disruption of cell cycle kinetics by benzo[a]pyrene: Inverse expression patterns of BRCA-1 and p53 in MCF-7 cells arrested in S and G2. Neoplasia 2 (5), 460-470.
42. Dipple, A., Khan, Q. A., Page, J. E., Ponten, I., and Szeliga, J. (1999) DNA reactions, mutagenic action and stealth properties of polycyclic aromatic hydrocarbon carcinogens (review). Int. J. Oncol. 14 (1), 103-111.
43. Giangrande, P. H., Zhu, W., Schlisio, S., Sun, X., Mori, S., Gaubatz, S., and Nevins, J. R. (2004) A role for E2F6 in distinguishing G1/S-and G2/M-specific transcription. Genes Dev. 18 (23), 2941-2951.
44. Warbrick, E. (2000) The puzzle of PCNA's many partners. Bioessays 22 (11), 997-1006.
45. Ford, J. M. (2005) Regulation of DNA damage recognition and nucleotide excision repair: Another role for p53. Mutat. Res. 577 (1-2), 195-202.
46. He, H., and Sun, Y. (2006) Ribosomal protein S27L is a direct p53 target that regulates apoptosis. Oncogene 26 (19), 2707-2716.
47. Osley, M. A. (1991) The regulation of histone synthesis in the cell cycle. Annu. Rev. Biochem. 60, 827-861.
48. Ehrenhofer-Murray, A. E. (2004) Chromatin dynamics at DNA replication, transcription, and repair. Eur. J. Biochem. 271 (12), 2335-2349.
49. 1 checkpoint pathway. EMBO J. 23(5), 1133-1143.
50. Zhao, J. (2004) Coordination of DNA synthesis and histone gene expression during normal cell cycle progression and after DNA damage. Cell Cycle 3 (6), 695-697.
51. 1 in yeast expressing human cytochrome P450 1A2 using cDNA microarrays. Mutat. Res. 593 (1-2), 121-142.
52. Meehan, T., and Bond, D. M. (1984) Hydrolysis of benzo[a]pyrene diol epoxide and its covalent binding to DNA proceed through similar rate-determining steps. Proc. Natl. Acad. Sci. U.S.A. 81 (9), 2635-2639.
53. Stevens, R. G. (2005) Circadian disruption and breast cancer: From melatonin to clock genes. Epidemiology 16 (2), 254-258.
54. Gauger, M. A., and Sancar, A. (2005) Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res. 65 (15), 6828-6834.
55. Xia, L., Robinson, D., Ma, A. H., Chen, H. C., Wu, F., Qiu, Y., and Kung, H. J. (2002) Identification of human male germ cell-associated kinase, a kinase transcriptionally activated by androgen in prostate cancer cells. J. Biol. Chem. 277 (38), 35422-35433.